48,788
edits
Difference between revisions of "Renal oncocytosis"
Jump to navigation
Jump to search
→General
| Line 36: | Line 36: | ||
*Rare. | *Rare. | ||
*May be seen in the context of [[Birt–Hogg–Dubé syndrome]] or [[chronic renal failure]] or may be sporadic.<ref name=pmid23018240/> | *May be seen in the context of [[Birt–Hogg–Dubé syndrome]] or [[chronic renal failure]] or may be sporadic.<ref name=pmid23018240/> | ||
**Chronic renal failure seen in 50% of cases in one series.<ref name=pmid21239013>{{Cite journal | last1 = Adamy | first1 = A. | last2 = Lowrance | first2 = WT. | last3 = Yee | first3 = DS. | last4 = Chong | first4 = KT. | last5 = Bernstein | first5 = M. | last6 = Tickoo | first6 = SK. | last7 = Coleman | first7 = JA. | last8 = Russo | first8 = P. | title = Renal oncocytosis: management and clinical outcomes. | journal = J Urol | volume = 185 | issue = 3 | pages = 795-801 | month = Mar | year = 2011 | doi = 10.1016/j.juro.2010.10.068 | PMID = 21239013 }}</ref> | |||
==Gross== | ==Gross== | ||